https://t.co/6kTOIWBlCj — The Propell Group (@ThePropellGroup) February 12, 2018
Amgen ‘looking hard’ at striking deals using $27bn cash pile via @FT https://t.co/h6l2zkktvR — The Propell Group (@ThePropellGroup) February 11, 2018
https://t.co/IY3vkXp2lv — The Propell Group (@ThePropellGroup) February 11, 2018
https://t.co/lw1u7ByOFZ — The Propell Group (@ThePropellGroup) February 11, 2018
Amazon set to launch own delivery service, competing with UPS & FedEx… https://t.co/eRnqhZ4aRv — The Propell Group (@ThePropellGroup) February 10, 2018
Teva warns on revenue amid tough US drug pricing via @FT https://t.co/ZIw0Eqw2QU — The Propell Group (@ThePropellGroup) February 9, 2018
Winners and losers in the sharing economy https://t.co/jtJ89cacWg — The Propell Group (@ThePropellGroup) February 8, 2018
Tencent, Medopad ally to create AI-fueled medical chatbots https://t.co/eZ0OMWuYZG — The Propell Group (@ThePropellGroup) February 8, 2018
Forget the bravado — Elon Musk’s SpaceX achievement is stunning via @FT https://t.co/pz3U6OlCFy — The Propell Group (@ThePropellGroup) February 8, 2018
GlaxoSmithKline commits to dividend but cautions on generics via @FT https://t.co/hYDpdJPetP — The Propell Group (@ThePropellGroup) February 8, 2018